Definium Therapeutics, Inc. DFTX
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04
Definium Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,261,087 | $106.4M | 2.29% |
| TWO SIGMA INVESTMENTS, LP | 921,818 | $43.4M | 0.93% |
| Point72 Asset Management, L.P. | 483,980 | $22.8M | 0.49% |
| MILLENNIUM MANAGEMENT LLC | 376,076 | $17.7M | 0.38% |
| D. E. Shaw & Co., Inc. | 315,410 | $14.8M | 0.32% |
| AQR CAPITAL MANAGEMENT LLC | 134,152 | $6.3M | 0.14% |
| Duquesne Family Office LLC | 356,600 | $16,774 | 0.36% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.